Back to Journals » Journal of Pain Research » Volume 18
Pain, Progress, and Price: A Review of Conservative and Complementary Treatments for Low Back Pain
Authors Putra BH
, Sinuraya RK
, Suwantika AA
Received 3 July 2025
Accepted for publication 23 August 2025
Published 5 September 2025 Volume 2025:18 Pages 4599—4610
DOI https://doi.org/10.2147/JPR.S551372
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Houman Danesh
Berry H Putra,1 Rano K Sinuraya,2,3 Auliya A Suwantika2,3
1Master of Pharmacy Program, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia; 2Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia; 3Center of Excellence for Pharmaceutical Care Innovation (PHARCI), Universitas Padjadjaran, Sumedang, Indonesia
Correspondence: Rano K Sinuraya, Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia, Email [email protected]
Abstract: Low back pain (LBP) is a leading cause of global disability, with a 7.2% prevalence and up to 80% lifetime risk, substantially impairing functionality and imposing a major economic burden. This review evaluates the cost-effectiveness trade-offs between pharmacological and non-pharmacological therapies for non-specific LBP, drawing on recent, high-quality evidence from a comprehensive PubMed search. Evaluated approaches included physical therapy, pharmacological management, cognitive behavioral therapy (CBT), chiropractic manipulation, acupuncture, yoga, and massage therapy. Non-steroidal anti-inflammatory drugs (NSAIDs) remain widely prescribed, yet their safety concerns contrast with the more sustainable benefits of physical therapy and spinal manipulation, with specialized physical therapy yielding 74% greater improvement than conventional therapy combined with NSAIDs. Nevertheless, physical therapy faces limitations related to practitioner variability, accessibility in rural or low-resource settings, upfront costs, and patient adherence. CBT demonstrates significant psychosocial benefits but is constrained by limited availability of qualified practitioners, high costs, and the active participation required from patients. Complementary approaches such as acupuncture and yoga show moderate efficacy and potential economic benefits; however, evidence consistency, delivery infrastructure, and adherence remain challenges, with yoga in particular showing high dropout rates in low-resource contexts. Importantly, acupuncture and yoga may still provide valuable benefits as part of a multimodal strategy. However, the available evidence is heavily concentrated in high-income countries, while studies from low- and middle-income countries remain scarce and unevenly distributed. Only a few LMICs have reported findings, with particularly limited data from Southeast Asia, underscoring critical research gaps in these regions. No single therapy emerges as universally superior for non-specific LBP, as effectiveness depends on patient profile, healthcare context, and cost. These findings highlight the importance of integrated, scalable, and accessible multidisciplinary models aligned with the biopsychosocial framework to optimize long-term outcomes.
Keywords: low back pain, conservative treatment, complementary medicine, cost effectiveness, pharmacological therapy
Introduction
Low back pain (LBP) is a major global public health concern and one of the most costly musculoskeletal disorders worldwide.1 Beyond its impact on mobility and quality of life, LBP ranks among the leading causes of disability, with a global prevalence estimated at 7.2%.2,3 The economic toll is equally significant: in the United States, direct annual treatment expenditures exceed USD 77 billion, while indirect costs from lost productivity and long-term disability add billions more.4 This dual burden of disability and cost underscores the urgent need for effective and economically sustainable management strategies.
From an epidemiological perspective, the prevalence of LBP varies considerably across regions.1 In Indonesia, national surveys report prevalence rates between 15% and 30% among adults, making it one of the most common musculoskeletal disorders in the country.5,6 This high prevalence is compounded by risk factors such as sedentary lifestyles, physically demanding occupations, and poor workplace ergonomics, all of which are expected to increase with demographic aging and shifting occupational patterns.7 Furthermore, Indonesian health authorities have reported that LBP frequently presents as neuropathic pain, particularly among individuals over 40 years of age, with incidence rates rising steadily.7,8
Clinically, LBP is defined as pain localized between the lower rib margin and the gluteal folds, with or without radiation to the lower limbs.2 It is broadly categorized as specific, when attributable to identifiable pathologies such as fractures, infections, or neoplasms, or non-specific, which accounts for the majority of cases.2,9 Non-specific LBP is commonly associated with soft tissue abnormalities, muscle strain, ligament or tendon injuries, spasms, or postural fatigue, and is often exacerbated by suboptimal occupational or lifestyle factors.9
Pathophysiologically, LBP arises from complex interactions among mechanical, neurological, and psychosocial processes.10 Reflecting this multifactorial nature, clinical practice guidelines recommend a stepwise treatment approach.9 For acute presentations, initial management includes reassurance, patient education, encouragement of physical activity, and pharmacological therapies such as acetaminophen or nonsteroidal anti-inflammatory drugs (NSAIDs).11 When symptoms persist or become chronic, non-pharmacological interventions—including structured exercise, physical therapy, chiropractic care, and cognitive-behavioral therapy—are generally recommended. In recent years, complementary and alternative therapies such as acupuncture, yoga, and massage have gained recognition for their potential role in managing chronic LBP.11,12
Although many cases of LBP are nonspecific and self-limiting, persistent pain can lead to significant physical impairment, psychological distress, and escalating healthcare costs.13 Importantly, most high-quality evidence on treatment effectiveness and cost-effectiveness originates from high-income countries.14 By contrast, studies from low- and middle-income countries (LMICs) remain scarce and geographically uneven, with only a few LMICs—particularly in Southeast Asia—reporting substantial findings.15,16 This disparity limits understanding of how effective or feasible these treatment options are in resource-constrained settings.
Given the growing global and regional burden of LBP, its substantial economic implications, and the expanding range of both conservative and complementary treatment options, there is a pressing need to synthesize available evidence. This narrative review therefore aims to critically evaluate the clinical effectiveness and cost-efficiency of pharmacological, non-pharmacological, and complementary treatments for LBP, with particular emphasis on treatment accessibility, variability in implementation, and implications for evidence-based practice and healthcare policy development.
Methods
This narrative review synthesizes findings from peer-reviewed articles and clinical guidelines retrieved from PubMed. A comprehensive database search was conducted in May 2025 using the following keywords in the advanced search function: (“low back pain” OR “lumbar pain” OR “chronic back pain”) AND (“treatment” OR “management” OR “intervention”) AND (“cost effectiveness” OR “economic evaluation” OR “cost utility”). The inclusion criteria were: (1) articles published in English, (2) publication types limited to systematic reviews, original research articles, clinical studies, or randomized controlled trials (RCTs), and (3) studies published within the past 10 years (2015–2025). Exclusion criteria included editorials, opinion pieces, and conference abstracts.
A total of 397 articles were initially retrieved from the PubMed search. Following title and abstract screening, 83 full-text articles were assessed for eligibility. Of these, 28 studies met all inclusion criteria and were included in the final synthesis. The selected articles were manually reviewed for relevance, and data were extracted on the following parameters: type of LBP treatment, classification as pharmacological or non-pharmacological, and reported cost-effectiveness outcomes.
Conservative Treatment
Physical Therapy
Clinical Effectiveness
Treatment for low back pain (LBP) often includes clinic-based physical therapy (PT), which may involve high-heat muscle relaxation, muscle stimulation, and ultrasound therapy. These modalities have demonstrated consistent effectiveness in pain management.17 PT generally produces better outcomes than medical treatment alone or no treatment at all.17,18
Cost-benefit studies show that early initiation of PT for acute LBP results in superior outcomes compared to either delayed treatment or standard medical intervention, with benefits persisting at one-year follow-up.19 Numerous randomized controlled trials (RCTs) confirm that PT significantly reduces pain intensity, enhances physical function, and improves quality of life for patients with acute, subacute, and chronic LBP.19,20
For example, combining spinal stabilization exercises with conventional PT has been shown to improve functional outcomes, reduce pain, and enhance health-related quality of life.21 Exercise therapy is widely recognized as a low-risk intervention compared to pharmacological options such as NSAIDs, which carry higher risks due to comorbidities like cardiovascular and gastrointestinal disease.21–23
Importantly, specialized PT has been shown to reduce disability scores by 51.7%, whereas conventional PT combined with NSAIDs achieved only a 29.6% reduction—representing a 74% greater improvement with specialized PT.23–25 This highlights that exercise-based therapy not only avoids medication-related risks but also provides greater functional benefits.
Cost Effectiveness
PT is considered a cost-effective strategy for managing LBP, particularly when initiated early.26 At one-year follow-up, PT has been found to be more cost-effective than usual primary care for acute and nonspecific LBP.19 Specific PT modalities, such as stretching and strengthening exercises, have proven especially effective in reducing pain intensity.19,26
One economic study reported that early PT was associated with an additional $580 in costs over one year, alongside a quality-adjusted life year (QALY) gain of 0.02.19 The incremental cost-effectiveness ratio (ICER) was calculated at $32,058 per QALY—well within conventional willingness-to-pay thresholds. Furthermore, early PT initiation has been associated with up to a 60% reduction in total care costs compared to delayed or passive treatment.19,27
Limitations
Despite its benefits, physical therapy has several limitations. The variation in methods among practitioners leads to inconsistent clinical outcomes. Access to physical therapy remains a challenge in rural areas or developing countries. Although generally efficient, the initial costs can still pose a barrier, particularly for patients without health insurance. Furthermore, not all patients respond optimally to therapy, as psychosocial factors, commitments, comorbidities, or fear-avoidance behaviors can influence therapeutic success. The lack of individualized approaches and the excessive use of passive modalities also contribute to the low effectiveness.28,29
Pharmacological Therapy
Drug Types and the WHO Pain Ladder
Pharmacological management—most commonly with nonsteroidal anti-inflammatory drugs (NSAIDs)—remains a standard option for LBP.30 The World Health Organization (WHO) advocates a stepwise approach to pain management, progressing from acetaminophen and NSAIDs to muscle relaxants, tramadol, corticosteroids, and, in select cases, short-term opioids for moderate-to-severe pain.2,30
In primary care, NSAIDs combined with muscle relaxants are frequently prescribed, typically administered on a scheduled basis rather than “as needed” to optimize pain relief.31 Patients often experience symptom improvement within one week, although the effect is less pronounced compared with either medication used alone.31,32 Opioids are reserved for short-term relief in severe cases but carry substantial risks. NSAID therapy, however, is sometimes discontinued due to adverse effects.24,32
Benefits and Risks NSAID Use
Despite being inexpensive and widely available, NSAIDs are associated with significant safety concerns, including gastrointestinal (GI) bleeding, impaired renal function, and cardiovascular (CV) adverse events (AEs), particularly with prolonged use.23,33 While NSAID administration has been shown to reduce pain and functional impairment in patients with persistent low back pain, NSAIDs alone have not demonstrated superior efficacy in managing acute LBP compared to physical therapy or spinal manipulation.3,34 In rehabilitation settings, targeted physical therapy interventions have consistently produced more favorable outcomes—reducing pain intensity and improving functional activity—than standard NSAID treatment.24
Cognitive-Behavioral Therapy (CBT)
Mechanism and Outcomes
Cognitive behavioral therapy (CBT) is a widely used non-pharmacological intervention that encompasses psychoeducation about pain, cognitive restructuring, problem-solving, relaxation techniques, and behavioral activation. It has been shown to be effective in managing chronic pain.11,35 Guidelines from the American College of Physician, the American Pain Society, the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society recommend considering CBT for patients with LBP.36–39
CBT stands out among psychotherapeutic options because it targets modifiable risk factors.40 It influences pain and disability outcomes by addressing fear-avoidance behaviors and catastrophizing.40,41 Fear-avoidance predicts impairment and directly impacts functional ability, while catastrophizing—closely linked to anxiety and depression—contributes to greater pain intensity and disability, and mediates the effects of factors such as education level and mood disorders.41 Overall, CBT has demonstrated superior outcomes compared to other interventions for nonspecific LBP, particularly when contrasted with back pain education or manual therapy.42
Cost Effectiveness Evidence
Given the clinical evidence supporting its effectiveness, there is considerable interest in evaluating the cost-effectiveness of CBT.39 The available evidence suggests that CBT may be cost-effective, although findings are not yet conclusive.39,43 Several studies—conducted from employer, societal, and national healthcare perspectives—have reported cost-effectiveness under varying conditions.43,44 While initial expenses can be substantial, long-term benefits and reductions in healthcare utilization contribute to its overall economic value.42 One study reported that the mean incremental cost per participant to society was $125, while the incremental cost per participant to the health plan was $495. These costs (and associated savings) corresponded with statistically significant QALY gains of 0.041 for CBT compared with usual care.44
Limitations and Future Directions
Despite growing evidence supporting CBT as an effective intervention for managing LBP, several limitations constrain its widespread application and clinical impact. Access to qualified CBT practitioners is often limited in rural, remote, or resource-constrained settings. In addition, patient adherence can be challenging, as CBT requires active participation, self-reflection, and sustained behavioral change.
To address these challenges, emerging research has proposed strategies to enhance the reach, effectiveness, and sustainability of CBT in LBP management. Future models should integrate CBT within interdisciplinary rehabilitation programs that combine physical therapy, patient education, and pharmacological management when appropriate. Such integration is consistent with biopsychosocial models and has demonstrated superior outcomes in chronic pain populations.
The adoption of internet-based CBT (iCBT) and mobile applications also offers a promising solution to overcome access barriers.45 Several randomized controlled trials have shown that iCBT is non-inferior to face-to-face CBT in reducing pain and improving function among LBP patients. These digital platforms additionally allow for self-paced learning and contribute to reduced healthcare costs.45,46
Complementary and Alternative Therapies
Spinal Manipulation/Chiropractic
Techniques and Use Prevalence
Spinal manipulation therapy (SMT) is the most commonly used provider-based complementary approach for low back pain (LBP).47 It involves manual techniques, including high-velocity, low-amplitude thrusts and low-velocity, variable-amplitude mobilization maneuvers. In the management of LBP, SMT is typically applied to the lumbar vertebrae or sacroiliac joints with the aim of restoring mobility and alleviating pain.47,48
Recent clinical guidelines strongly endorse SMT, particularly when combined with exercise, as a first-line treatment before initiating pharmacological interventions.49 Rehabilitative exercise—designed to instruct and motivate patients to manage their LBP and prevent recurrence—is often integrated with SMT to promote patient self-efficacy.49,50
Chiropractic care is frequently sought by patients with LBP for spinal manipulation.49 For example, in Denmark, nearly one-third of individuals with back pain consult a chiropractor as their initial point of care.51 More recent systematic reviews evaluating SMT have incorporated both randomized and non-randomized studies, concluding that SMT is as effective as other widely used treatment options.49 Although SMT is a cornerstone of chiropractic care, practitioners often employ multimodal treatment strategies to optimize outcomes. Moreover, SMT is also provided by osteopaths, physiotherapists, and other trained healthcare professionals. As such, while studies of SMT effectiveness help guide clinicians in treatment selection, they provide limited direction to patients regarding which type of provider they should consult.49,51
Clinical Effectiveness and Economic Evidence
SMT is commonly delivered by chiropractors, osteopaths, or trained physiotherapists and is widely used as a non-pharmacological intervention for low back pain (LBP). Its effectiveness has been evaluated in numerous randomized controlled trials (RCTs) and systematic reviews.49 Evidence from a systematic review and meta-analysis indicated that SMT provides modest improvements in pain and functional outcomes for patients with acute LBP compared with placebo or usual care.49,52 These benefits are most apparent in the short term (up to six weeks), while long-term advantages remain inconclusive. The magnitude of effect is similar to that of other recommended interventions, such as exercise therapy and nonsteroidal anti-inflammatory drugs (NSAIDs).49
Economic analyses further support SMT when used in combination with other treatments. RCT evidence has shown that, compared with chiropractic care alone, combination treatment strategies (eg, SMT plus exercise or education) resulted in quality-adjusted life year (QALY) gains and lower healthcare costs.53 From a Swedish healthcare perspective, combination treatment was considered cost-effective at a willingness-to-pay threshold of SEK 900,000 per QALY, with an incremental cost-effectiveness ratio (ICER) of SEK 850,000 compared to chiropractic care alone.54
Acupuncture
Mechanism
Acupuncture originated in China more than 4000 years ago and is rooted in traditional Chinese medicine, which posits that the body’s vital energy (Qi) circulates through 12 primary and eight secondary meridians.55 The insertion of needles into specific points along these meridians—whether manipulated or not—is believed to restore the proper flow of Qi. Patients often experience a sensation known as De Qi, described as soreness, fullness, numbness, or tingling, during needle manipulation.55,56
Dry needling, often referred to as myofascial trigger point needling, resembles acupuncture when applied at Ah Shi points, which correspond to trigger or tender points within the myofascial tissue.57 This approach is now frequently termed myofascial acupuncture. Both acupuncture and dry needling may be augmented by additional stimulation methods, such as small electrical currents (electroacupuncture), moxibustion (the burning of the herb moxa on the needle handle), or heat lamps.57,58 However, an optimal treatment protocol for chronic LBP has yet to be established.
Clinical and Economic Findings
Acupuncture has been extensively studied as a non-pharmacological intervention for both acute and chronic LBP. High-quality RCTs and systematic reviews provide evidence of moderate clinical benefits, particularly for chronic LBP.59 In 2017, American College of Physicians (ACP) recommended acupuncture as a primary treatment option for chronic LBP, citing its ability to relieve pain and improve function.60
Supporting this, RCT findings from Skonnord et al61 demonstrated that acupuncture was cost-effective, yielding a QALY gain by day 365. At day 28, incremental QALY values were zero for both healthcare and societal perspectives. At a willingness-to-pay threshold of NOK 275,000, the probability of acupuncture being cost-effective based on healthcare costs was 46.1% at day 28 and 95.9% at day 365. From a societal perspective, the probabilities were 81.5% and 74.1%, respectively. Differences in healthcare and societal costs, however, were not statistically significant.
Limitations: Placebo Effects and Practitioner Expertise
The effectiveness of acupuncture can vary widely due to factors such as placebo responses and practitioner expertise, highlighting the importance of treatment by qualified professionals.59 Contextual elements—including patient expectations, therapist–patient interactions, and the ritualistic aspects of treatment—may significantly influence perceived benefits beyond needle placement or meridian theory.62
Acupuncture is not a uniform intervention; it encompasses diverse styles (eg, traditional Chinese, Japanese, Western medical acupuncture, and electroacupuncture) that differ in insertion depth, point selection, stimulation intensity, and treatment duration.63 Clinical outcomes therefore vary according to practitioner training and technical skill. Inexperienced practitioners may fail to achieve therapeutic benefits, whereas highly experienced practitioners might unintentionally amplify nonspecific effects (eg, through confidence and communication), complicating the interpretation of trial outcomes.64 Furthermore, the absence of standardized protocols across studies reduces reproducibility and limits the generalizability of findings.59
Yoga and Massage Therapy
Functional Outcomes
Clinical guidelines for chronic low back pain (CLBP) from the American College of Physicians recommend a stepped-care strategy that begins with nonpharmacological approaches, such as yoga and physical therapy, progresses to nonopioid medications, and reserves opioids for cases in which the potential benefits clearly outweigh the risks.60 Within this framework, therapeutic yoga is recognized as an evidence-based intervention, supported by multiple randomized controlled trials (RCTs), systematic reviews, and meta-analyses demonstrating its effectiveness in reducing pain intensity and improving back-related function.65 Similarly, a Cochrane Review update on massage therapy reported that massage can improve pain outcomes in patients with acute, subacute, and chronic LBP, although these benefits were limited to the short term. Functional improvements were also noted in subacute and chronic LBP when compared with inactive controls, but again only in the short term. Reported adverse effects of massage were generally minor.66,67
Comparative Effectiveness
Yoga has been shown to be at least as effective as physical therapy for CLBP.68 However, recommending yoga depends on several factors: the availability of qualified instructors, the presence of CLBP-specific yoga programs, clinician familiarity with the evidence, and patient and provider preferences. Access through healthcare systems or insurance coverage remains relatively rare.65,68
From a health system perspective, the incremental cost-effectiveness ratio (ICER) of yoga was estimated at $4488 per quality-adjusted life year (QALY). From a societal perspective, yoga was considered “dominant”, offering both improved health outcomes and cost savings. Probabilistic sensitivity analysis revealed an 89% probability of yoga being cost-effective at a willingness-to-pay threshold of $50,000. Furthermore, comparative studies suggest that yoga can achieve outcomes comparable to physical therapy at a substantially lower cost.69
Access and Insurance Considerations
Despite demonstrated clinical benefits, yoga faces significant barriers to widespread implementation, including limited accessibility, affordability, and insurance coverage. RCTs report an average dropout rate of 11.4%, which increases to 15.2% for interventions lasting more than 12 weeks, and can exceed 40% among socioeconomically disadvantaged or medically vulnerable populations.70 In low-resource settings, adherence is further challenged by high out-of-pocket costs, restricted insurance coverage, limited access to trained instructors, and logistical issues such as scheduling conflicts or travel requirements.71 Additional barriers include misconceptions (eg, yoga is ineffective for weight loss), fear of injury, and low motivation for home practice. These challenges contribute to higher dropout rates in real-world settings, reflected in lower participation rates among lower-income adults (10.4% among those earning less than 200% of the federal poverty level versus 23.0% among those earning 400% or more).70,71 Insurance reimbursement gaps further restrict access for lower-income populations, exacerbating disparities in utilization.
Summary of Cost-Effectiveness Findings Across Modalities
A wide range of conservative treatments—including exercise, physical therapy, and medication—are used to manage LBP, with the goals of improving mobility, reducing pain, and enhancing both functional and psychological well-being. Physical therapy (PT) is frequently recommended as a first-line treatment for both acute and chronic LBP. Cost-utility analyses have shown that early PT intervention is associated with an incremental cost-effectiveness ratio (ICER) of $32,058 per quality-adjusted life year (QALY) gained, well below conventional willingness-to-pay thresholds.19 Moreover, early PT initiation has been linked to a 60% reduction in subsequent healthcare costs compared to delayed or passive care, underscoring its value in long-term management.72
Pharmacological treatment of LBP generally follows the World Health Organization (WHO) pain management ladder, progressing from acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) to muscle relaxants, tramadol, corticosteroids, and, when necessary, opioids for severe pain. NSAIDs—often combined with muscle relaxants—are widely used in primary care and can provide symptomatic relief within one week.2,30,31 However, their effectiveness is modest when used alone, and they pose risks such as gastrointestinal bleeding, renal impairment, and cardiovascular events, particularly with long-term use.23 While NSAIDs improve pain and function in chronic LBP, they are less effective than non-pharmacological interventions such as PT or spinal manipulation for acute cases, which offer better functional outcomes and lower risk profiles.73
Cognitive behavioral therapy (CBT) has demonstrated clinical effectiveness in addressing psychosocial contributors to chronic LBP.74 Maladaptive thought processes can exacerbate pain perception and disability by influencing emotional states and behavior.75 CBT targets these mechanisms through structured interventions, leading not only to improved pain and functional outcomes but also to reductions in healthcare utilization. When combined with PT, CBT further enhances outcomes by addressing psychosocial risk factors alongside physical impairments.42 From a societal perspective, CBT has demonstrated a favorable cost-effectiveness profile, with an estimated incremental cost of $3049 per QALY gained and an average incremental societal cost of $125 per participant, resulting in a QALY gain of 0.041 compared to usual care.44 These findings highlight the economic feasibility of CBT as part of interdisciplinary care, though barriers remain related to initial implementation costs and limited availability of trained providers.
Spinal manipulation therapy (SMT), commonly provided by chiropractors, has been associated with modest short-term improvements in pain and function. A cost-effectiveness analysis from a Swedish healthcare perspective estimated an ICER of SEK 850,000 per QALY for integrated SMT interventions, remaining below the national threshold of SEK 900,000.54 The addition of exercise or educational components further improved cost utility, suggesting that multimodal approaches are more efficient. In a large study of more than 72,000 older adults with multiple chronic conditions and LBP, those receiving chiropractic care had lower overall healthcare expenditures and reduced costs per episode day compared to those receiving conventional medical treatment.76 However, some studies that assessed both clinical outcomes and costs reported higher expenditures, suggesting that while SMT is probably cost-effective, its economic impact may vary depending on context.77
Acupuncture has also demonstrated moderate clinical benefits in chronic LBP, though cost-effectiveness results vary by setting. A Norwegian study61 found acupuncture to be cost-effective in 95.9% of simulations at a willingness-to-pay threshold of NOK 275,000 per QALY from a healthcare perspective. Cost-effectiveness probabilities from a societal perspective remained substantial (74.1–81.5%), although differences in overall costs were not statistically significant. These findings support acupuncture as a feasible adjunct therapy, particularly for chronic or refractory LBP. In line with growing evidence, the American College of Physicians recommends acupuncture as a first-line non-pharmacological treatment for chronic LBP. However, further cost-effectiveness research is needed to clarify its long-term economic and clinical impact.
Among complementary and alternative medicine (CAM) therapies, yoga has shown particular promise. Medical yoga has demonstrated the ability to alter pain perception and produce lasting improvements in back function. Compared with evidence-based self-care advice, yoga is associated with greater improvements in health-related quality of life (HRQL). From a societal perspective, yoga is more likely to be cost-effective than exercise therapy or self-care recommendations. Studies also suggest cost-effectiveness from the employer perspective, as improvements in HRQL may enhance productivity, thereby offsetting the costs of yoga programs delivered through occupational health services.78 A randomized trial estimated an ICER of $4488 per QALY gained, with an 89% probability of cost-effectiveness at a $50,000 threshold. From a societal perspective, yoga was considered “dominant”, offering both improved outcomes and reduced costs.69 Nonetheless, widespread implementation remains limited by variable insurance coverage and restricted access to clinically tailored yoga programs.
Perspectives on Integration Into Healthcare Systems
Integrating evidence-based strategies for managing low back pain (LBP) into healthcare systems is essential for improving patient outcomes, reducing chronic disability, and optimizing resource utilization. Current guidelines emphasize a multidisciplinary, stepped-care approach that combines pharmacological, physical, psychological, and complementary therapies.2,30 However, implementation varies widely across settings due to disparities in access, provider training, infrastructure, and reimbursement policies. Conventional treatments such as physical therapy and NSAIDs are generally well-established in primary care, though timely referral to physical therapy remains inconsistent. Psychological interventions, including cognitive behavioral therapy (CBT), are strongly recommended for chronic LBP but remain underutilized because of limited access to trained providers and inadequate insurance coverage. Complementary therapies such as acupuncture, spinal manipulation, and yoga demonstrate favorable cost-effectiveness but are seldom reimbursed and are often delivered outside formal medical systems, which restricts scalability. Strategies to improve integration include embedding non-pharmacological treatments into primary care and rehabilitation services, broadening insurance coverage for validated interventions, and enhancing education and collaboration across multidisciplinary teams. Digital innovations—such as internet-based CBT (iCBT) and virtual physical therapy—offer scalable solutions to overcome geographic and logistical barriers. Ultimately, successful integration depends on supportive policies, strong clinical infrastructure, and patient-centered delivery models that align with the biopsychosocial framework for managing LBP.
The integration of evidence-based strategies for managing LBP within healthcare systems is crucial for enhancing patient outcomes, minimizing chronic disability, and maximizing resource utilization. Current guidelines emphasize a multidisciplinary and stepped-care approach, combining pharmacological, physical, psychological, and complementary therapies. However, implementation varies widely across settings due to disparities in access, provider training, infrastructure, and reimbursement policies. Conventional treatments such as physical therapy and NSAIDs are typically well-implemented in primary care setting, though early referral to physical therapy remains inconsistent. Cognitive behavioral therapy and other psychological approaches are recommended for chronic LBP but are underutilized due to limited access to trained professionals and inadequate insurance coverage. Complementary therapies such as acupuncture, spinal manipulation, and yoga show favorable cost-effectiveness but are rarely covered by insurance and often delivered outside formal medical settings, limiting scalability. Initiatives aimed at improving integration involve incorporating non-pharmacologic treatments into primary care, rehabilitation services, and digital platforms, broadening insurance coverage for validated interventions, and educating multidisciplinary teams. Innovations in digital health, such as internet-based CBT (iCBT) and virtual physical therapy, present scalable solutions to address geographic and logistical challenges. The successful integration of these approaches relies on supportive policies, robust clinical infrastructure, and patient-centered delivery models that are consistent with the biopsychosocial framework for managing LBP.
Recommendations for Future Research and Practice
Future research and clinical practice in the management of LBP should prioritize interventions that are personalized, cost-efficient, and widely accessible. Key priorities include conducting long-term comparative studies, particularly on non-pharmacological therapies; strengthening economic evaluations in low-resource settings; and expanding the use of digital solutions such as tele-rehabilitation and internet-based CBT to improve access. Developing stratified care models informed by patient risk profiles, enhancing interdisciplinary collaboration, and advancing workforce training are also critical for improving treatment adherence and outcomes. Finally, addressing equity issues—such as gaps in insurance coverage and shortages of qualified providers—will be essential for achieving effective, patient-centered management of LBP.
Conclusion
Low back pain (LBP) remains a leading global cause of disability and economic burden, requiring treatment strategies that are both evidence-based and cost-conscious. No single therapy has proven consistently superior for non-specific LBP, emphasizing the need for flexible, patient-centered care. Conservative interventions such as early physical therapy and cognitive behavioral therapy (CBT), along with complementary options like acupuncture, spinal manipulation, and yoga, demonstrate meaningful clinical benefits and favorable cost-effectiveness when integrated into comprehensive care. However, limited access, inconsistent reimbursement, and infrastructure gaps hinder widespread adoption. To advance LBP management, health systems should prioritize multidisciplinary approaches and incorporate incremental cost-effectiveness ratio (ICER) thresholds into national reimbursement frameworks, alongside expanding insurance coverage and digital delivery models. Aligning clinical effectiveness with cost-efficiency will be critical for sustainable, patient-centered care.
Disclosure
The authors have no conflicts of interest to disclose in this work.
References
1. Ferreira ML, de Luca K, Haile LM, et al. Global, regional, and national burden of low back pain, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(6):e316–e329. doi:10.1016/S2665-9913(23)00098-X
2. World Health Organization. Low back pain. 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/low-back-pain.
3. Wu A, March L, Zheng X, et al. Global low back pain prevalence and years lived with disability from 1990 to 2017: estimates from the global burden of disease study 2017. Ann Transl Med. 2020;8(6):299. doi:10.21037/atm.2020.02.175
4. Kim SK, Min A, Jeon C, et al. Clinical outcomes and cost-effectiveness of massage chair therapy versus basic physiotherapy in lower back pain patients: a randomized controlled trial. Medicine. 2020;99(12):e19514. doi:10.1097/MD.0000000000019514
5. The Ministry of Health of Indonesia. Riset kesehatan dasar Indonesia. 2018. Available from: http://labdata.litbang.kemkes.go.id/images/download/laporan/RKD/2018/Laporan_Nasional_RKD2018_FINAL.pdf.
6. Susanto H, Dang LT, Winitchayothin S, Hidayat J, Pradana AA. Low back pain prevalence in indonesian older adults: systematic review and meta-analysis. Pain Manag Nurs. 2025. doi:10.1016/j.pmn.2025.07.004
7. Makkiyah FA, Sinaga TA, Khairunnisa N. A study from a highly populated country: risk factors associated with lower back pain in middle-aged adults. J Korean Neurosurg Soc. 2023;66(2):190–198. doi:10.3340/jkns.2021.0278
8. Novy TCT, Fonda G, Suwadi A. Cases, prevalence and treatment of low back pain at Bandung pain rehab. Indonesian J Phys Med Rehab. 2023;12(1):52–60. doi:10.36803/indojpmr.v12i01.338
9. Delitto A, George SZ, Van Dillen L, et al. Low back pain. J Orthop Sports Phys Ther. 2012;42(4):A1–A57. doi:10.2519/jospt.2012.42.4.A1
10. Li W, Gong Y, Liu J, et al. Peripheral and central pathological mechanisms of chronic low back pain: a narrative review. J Pain Res. 2021;14:1483–1494. doi:10.2147/JPR.S306280
11. Sharif S, Jazaib Ali MY, Kirazlı Y, Vlok I, Zygourakis C, Zileli M. Acute back pain: the role of medication, physical medicine and rehabilitation: WFNS spine committee recommendations. World Neurosurg X. 2024;23:100273. doi:10.1016/j.wnsx.2024.100273
12. Knezevic NN, Candido KD, Vlaeyen JWS, Van Zundert J, Cohen SP. Low back pain. Lancet. 2021;398(10294):78–92. doi:10.1016/S0140-6736(21)00733-9
13. Khodakarami N. Treatment of patients with low back pain: a comparison of physical therapy and chiropractic manipulation. Healthcare. 2020;8(1):44. doi:10.3390/healthcare8010044
14. Sharma S, Pathak A, Parker R, et al. How low back pain is managed—a mixed-methods study in 32 countries. part 2 of low back pain in low- and middle-income countries series. J Orthop Sports Phys Ther. 2024;54(8):560–572. doi:10.2519/jospt.2024.12406
15. Ghafouri M, Ghasemi E, Rostami M, et al. The quality of care index for low back pain: a systematic analysis of the global burden of disease study 1990-2017. Arch Public Health. 2023;81(1):167. doi:10.1186/s13690-023-01183-3
16. Yiengprugsawan V, Hoy D, Buchbinder R, Bain C, Seubsman SA, Sleigh AC. Low back pain and limitations of daily living in Asia: longitudinal findings in the Thai cohort study. BMC Musculoskelet Disord. 2017;18(1):19. doi:10.1186/s12891-016-1380-5
17. Şahin N, Karahan AY, Albayrak İ. Effectiveness of physical therapy and exercise on pain and functional status in patients with chronic low back pain: a randomized-controlled trial. Turk J Phys Med Rehabil. 2018;64(1):52–58. doi:10.5606/tftrd.2018.1238
18. Shipton EA. Physical therapy approaches in the treatment of low back pain. Pain Ther. 2018;7(2):127–137. doi:10.1007/s40122-018-0105-x
19. Fritz JM, Kim M, Magel JS, Asche CV. Cost-effectiveness of primary care management with or without early physical therapy for acute low back pain: economic evaluation of a randomized clinical trial. Spine. 2017;42(5):285–290. doi:10.1097/BRS.0000000000001729
20. Lin CW, Haas M, Maher CG, Machado LA, van Tulder MW. Cost-effectiveness of guideline-endorsed treatments for low back pain: a systematic review. Eur Spine J. 2011;20(7):1024–1038. doi:10.1007/s00586-010-1676-3
21. Alkhathami K, Alshehre Y, Brizzolara K, Weber M, Wang-Price S. Effectiveness of spinal stabilization exercises on movement performance in adults with chronic low back pain. Int J Sports Phys Ther. 2023;18(1):169–172. doi:10.26603/001c.68024
22. George SZ, Fritz JM, Silfies SP, et al. Interventions for the management of acute and chronic low back pain: revision 2021. J Orthop Sports Phys Ther. 2021;51(11):CPG1–CPG60. doi:10.2519/jospt.2021.0304
23. Kikuchi S, Togo K, Ebata N, et al. A retrospective database study of gastrointestinal events and medical costs associated with nonsteroidal anti-inflammatory drugs in japanese patients of working age with osteoarthritis and chronic low back pain. Pain Med. 2021;22(5):1029–1038. doi:10.1093/pm/pnaa421
24. Das SK, Khan AH, Islam MS, et al. Specialized physiotherapy and pharmacological management strategies in optimizing chronic lower back pain rehabilitation. J Angiother. 2024;8(5).
25. Kant S, Urvashi JK, Raman RK. Effectiveness of core stabilization exercises vs. traditional physical therapy for chronic low back pain. J Contemp Clin Pract. 2024;10(2):279–287.
26. Fatoye F, Wright JM, Gebrye T. Cost-effectiveness of physiotherapeutic interventions for low back pain: a systematic review. Physiotherapy. 2020;108:98–107. doi:10.1016/j.physio.2020.04.010
27. Ebell MH. Early PT for acute low back pain is cost-effective, but gain in quality of life is likely too small to notice. Am Fam Physician. 2018;97(7):475.
28. O’Keeffe M, Cullinane P, Hurley J, et al. What influences patient-therapist interactions in musculoskeletal physical therapy? Qualitative systematic review and meta-synthesis. Phys Ther. 2016;96(5):609–622. doi:10.2522/ptj.20150240
29. van Middelkoop M, Rubinstein SM, Kuijpers T, et al. A systematic review on the effectiveness of physical and rehabilitation interventions for chronic non-specific low back pain. Eur Spine J. 2011;20(1):19–39. doi:10.1007/s00586-010-1518-3
30. World Health Organization. WHO releases guidelines on chronic low back pain. 2023. Available from: https://www.who.int/news/item/07-12-2023-who-releases-guidelines-on-chronic-low-back-pain.
31. Saindane RA, Thombre NA. Concurrent use of skeletal muscle relaxants and NSAIDs in low back pain management: a critical review of current evidence and future directions. J Pharm Sci. 2025;49(2):5. doi:10.56808/3027-7922.2997
32. Patel HD, Uppin RB, Naidu AR, Rao YR, Khandarkar S, Garg A. Efficacy and safety of combination of NSAIDs and muscle relaxants in the management of acute low back pain. Pain Ther. 2019;8(1):121–132. doi:10.1007/s40122-019-0112-6
33. Al-Saeed A. Gastrointestinal and cardiovascular risk of nonsteroidal anti-inflammatory drugs. Oman Med J. 2011;26(6):385–391. doi:10.5001/omj.2011.101
34. Nasim ASM, Siddique AB, Devnath N, Zeba Z. Assessment of the prevalence and associated factors of lower back pain (LBP) among three different professionals in Bangladesh: findings from a face-to-face survey. BMJ Open. 2024;14(4):e082849. doi:10.1136/bmjopen-2023-082849
35. Sanabria-Mazo JP, Colomer-Carbonell A, Fernández-Vázquez Ó, et al. A systematic review of cognitive behavioral therapy-based interventions for comorbid chronic pain and clinically relevant psychological distress. Front Psychol. 2023;14:2023. doi:10.3389/fpsyg.2023.1200685
36. Qaseem A, Wilt TJ, McLean RM, et al. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;166(7):514–530. doi:10.7326/M16-2367
37. American Pain Society. Study shows cognitive behavioral therapy improves functioning for people with chronic pain. 2017. Available from: https://americanpainsociety.org/about-us/press-room/study-shows-cognitive-behavioral-therapy-improves-functioning-for-people-with-chronic-pain.
38. Airaksinen O, Brox JI, Cedraschi C, et al. Chapter 4. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J. 2006;15:s192–s300. doi:10.1007/s00586-006-1072-1
39. Norton G, McDonough CM, Cabral H, Shwartz M, Burgess JF. Cost-utility of cognitive behavioral therapy for low back pain from the commercial payer perspective. Spine. 2015;40(10):725–733. doi:10.1097/BRS.0000000000000830
40. Abdelhaleem MD, Aly SM, Taha TS, Abdallah EA. Effect of 8 weeks of cognitive behavioral therapy versus 8 weeks core stabilization training in the management of subjects with non-specific low back pain: a randomized controlled trial. Bulletin of Faculty of Physical Therapy. 2024;29(1):37. doi:10.1186/s43161-024-00198-3
41. Zhang Q, Xu H, Wang Y, Jiang J, Xue Q, Qiu Z. Efficacy of cognitive behavioral therapy for reducing pain susceptibility and increasing social engagement in patients with chronic low back pain: a systematic review and meta-analysis. Medicine. 2023;102(45):e35269. doi:10.1097/MD.0000000000035269
42. Mindouri A-S, Trevlaki E, Trevlakis E, Mallios N, Domatas G, Xristara-Papadopoulou A. The effectiveness of cognitive behavioral therapy in chronic low back pain. Biomed J Sci Tech Res. 2023;48(3):39646–39655.
43. Lamb SE, Hansen Z, Lall R, et al. Group cognitive behavioural treatment for low-back pain in primary care: a randomised controlled trial and cost-effectiveness analysis. Lancet. 2010;375(9718):916–923. doi:10.1016/S0140-6736(09)62164-4
44. Herman PM, Anderson ML, Sherman KJ, Balderson BH, Turner JA, Cherkin DC. Cost-effectiveness of mindfulness-based stress reduction versus cognitive behavioral therapy or usual care among adults with chronic low back pain. Spine. 2017;42(20):1511–1520. doi:10.1097/BRS.0000000000002344
45. Pan J-Y, Thew GR, Clark DM. Effectiveness of internet-based cognitive behavioral therapy with virtual reality exposure therapy for social anxiety disorder: a randomized controlled trial in Hong Kong. J Affective Disorders. 2025;383:228–239. doi:10.1016/j.jad.2025.04.100
46. Yang J, Lo WLA, Zheng F, Cheng X, Yu Q, Wang C. Evaluation of cognitive behavioral therapy on improving pain, fear avoidance, and self-efficacy in patients with chronic low back pain: a systematic review and meta-analysis. Pain Res Manag. 2022;2022:4276175. doi:10.1155/2022/4276175
47. Rubinstein SM, van Middelkoop M, Assendelft WJ, de Boer MR, van Tulder MW. Spinal manipulative therapy for chronic low-back pain. Cochrane Database Syst Rev. 2011;2011(2):Cd008112. doi:10.1002/14651858.CD008112.pub2
48. Rubinstein SM, de Zoete A, van Middelkoop M, Assendelft WJJ, de Boer MR, van Tulder MW. Benefits and harms of spinal manipulative therapy for the treatment of chronic low back pain: systematic review and meta-analysis of randomised controlled trials. BMJ. 2019;364(l689). doi:10.1136/bmj.l689
49. Nim C, Aspinall SL, Cook CE, et al. The effectiveness of spinal manipulative therapy in treating spinal pain does not depend on the application procedures: a systematic review and network meta-analysis. J Orthop Sports Phys Ther. 2025;55(2):109–122. doi:10.2519/jospt.2025.12707
50. Evans R, Haas M, Schulz C, Leininger B, Hanson L, Bronfort G. Spinal manipulation and exercise for low back pain in adolescents: a randomized trial. Pain. 2018;159(7):1297–1307. doi:10.1097/j.pain.0000000000001211
51. Blanchette MA, Stochkendahl MJ, Borges Da Silva R, Boruff J, Harrison P, Bussières A. Effectiveness and economic evaluation of chiropractic care for the treatment of low back pain: a systematic review of pragmatic studies. PLoS One. 2016;11(8):e0160037. doi:10.1371/journal.pone.0160037
52. Paige NM, Miake-Lye IM, Booth MS, et al. Association of spinal manipulative therapy with clinical benefit and harm for acute low back pain: systematic review and meta-analysis. JAMA. 2017;317(14):1451–1460. doi:10.1001/jama.2017.3086
53. Leininger B, McDonough C, Evans R, Tosteson T, Tosteson AN, Bronfort G. Cost-effectiveness of spinal manipulative therapy, supervised exercise, and home exercise for older adults with chronic neck pain. Spine J. 2016;16(11):1292–1304. doi:10.1016/j.spinee.2016.06.014
54. Gedin F, Skeppholm M, Sparring V, Zethraeus N. Effectiveness and cost-effectiveness of chiropractic and physiotherapy for chronic low back pain: a multicenter RCT in Sweden. BMC Musculoskelet Disord. 2025;26(1):190. doi:10.1186/s12891-025-08392-7
55. Berman BM, Langevin HM, Witt CM, Dubner R. Acupuncture for chronic low back pain. N Engl J Med. 2010;363(5):454–461. doi:10.1056/NEJMct0806114
56. Hao JJ, Mittelman M. Acupuncture: past, present, and future. Glob Adv Health Med. 2014;3(4):6–8. doi:10.7453/gahmj.2014.042
57. Dunning J, Butts R, Mourad F, Young I, Flannagan S, Perreault T. Dry needling: a literature review with implications for clinical practice guidelines. Phys Ther Rev. 2014;19(4):252–265. doi:10.1179/108331913X13844245102034
58. Mu J, Furlan AD, Lam WY, Hsu MY, Ning Z, Lao L. Acupuncture for chronic nonspecific low back pain. Cochrane Database Syst Rev. 2020;12(12):Cd013814. doi:10.1002/14651858.CD013814
59. Gao F, Jia D, Xue S. Comparative efficacy of acupuncture for chronic low back pain: a network meta-analysis. Heliyon. 2025;11(10):e43132. doi:10.1016/j.heliyon.2025.e43132
60. American College of Physicians. American College of Physicians issues guideline for treating nonradicular low back pain. 2017. Available from: https://www.acponline.org/acp-newsroom/american-college-of-physicians-issues-guideline-for-treating-nonradicular-low-back-pain#:~:text=low%20back%20pain-,American%20College%20of%20Physicians%20issues%20guideline%20for%20treating%20nonradicular%20low,NSAIDs)%20or%20skeletal%20muscle%20relaxants.
61. Skonnord T, Fetveit A, Skjeie H, et al. Cost-effectiveness analysis of acupuncture compared with usual care for acute non-specific low back pain: secondary analysis of a randomised controlled trial. Acupunct Med. 2022;40(2):123–132. doi:10.1177/09645284211055747
62. Liu W, Towell-Barnard A, Lee KH, Leen Kang T. Participants experiences regarding the use of acupuncture as a treatment modality: a qualitative systematic review. Complement Ther Clin Pract. 2024;57:101866. doi:10.1016/j.ctcp.2024.101866
63. Hal MV, Dydyk AM, Green MS. Acupuncture. 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532287/.
64. Li X, Dai Q, Shi Z, et al. Clinical efficacy and safety of electroacupuncture in migraine treatment: a systematic review and network meta-analysis. Am J Chin Med. 2019;47(8):1755–1780. doi:10.1142/S0192415X19500897
65. Tankha H, Gaskins D, Shallcross A, et al. Effectiveness of virtual yoga for chronic low back pain: a randomized clinical trial. JAMA Network Open. 2024;7(11):e2442339. doi:10.1001/jamanetworkopen.2024.42339
66. Furlan AD, Imamura M, Dryden T, Irvin E. Massage for low-back pain. Cochrane Database Syst Rev. 2008;4:Cd001929. doi:10.1002/14651858.CD001929.pub2
67. Furlan AD, Giraldo M, Baskwill A, Irvin E, Imamura M. Massage for low-back pain. Cochrane Database Syst Rev. 2015;2015(9):Cd001929. doi:10.1002/14651858.CD001929.pub3
68. Clark BC, Russ DW, Nakazawa M, et al. A randomized control trial to determine the effectiveness and physiological effects of spinal manipulation and spinal mobilization compared to each other and a sham condition in patients with chronic low back pain: study protocol for the relief study. Contemp Clin Trials. 2018;70:41–52. doi:10.1016/j.cct.2018.05.012
69. Groessl EJ, Liu L, Richard EL, Tally SR.Cost-effectiveness of Yoga for Chronic Low Back Pain in Veterans. Med Care.2020;58:S142–S148. doi:10.1097/MLR.0000000000001356
70. Cramer H, Haller H, Dobos G, Lauche R. A systematic review and meta-analysis estimating the expected dropout rates in randomized controlled trials on yoga interventions. Evid Based Complement Alternat Med. 2016;2016:5859729. doi:10.1155/2016/5859729
71. Shahidi B, Padwal J, Lee E, et al. Factors impacting adherence to an exercise-based physical therapy program for individuals with low back pain. PLoS One. 2022;17(10):e0276326. doi:10.1371/journal.pone.0276326
72. Childs JD, Fritz JM, Wu SS, et al. Implications of early and guideline adherent physical therapy for low back pain on utilization and costs. BMC Health Serv Res. 2015;15(1):150. doi:10.1186/s12913-015-0830-3
73. Jones CMP, Underwood M, Chou R, et al. Analgesia for non-specific low back pain. BMJ. 2024;385:e080064.
74. Lumley MA, Schubiner H. Psychological therapy for centralized pain: an integrative assessment and treatment model. Psychosom Med. 2019;81(2):114–124. doi:10.1097/PSY.0000000000000654
75. Songer D. Psychotherapeutic approaches in the treatment of pain. Psychiatry. 2005;2(5):19–24.
76. Weeks WB, Leininger B, Whedon JM, et al. The association between use of chiropractic care and costs of care among older medicare patients with chronic low back pain and multiple comorbidities. J Manipulative Physiol Ther. 2016;39(2):63–75.e62. doi:10.1016/j.jmpt.2016.01.006
77. Whedon JM, Bezdjian S, Dennis P, Fischer VA, Russell R. Cost comparison of two approaches to chiropractic care for patients with acute and sub-acute low back pain care episodes: a cohort study. Chiropr Man Therap. 2020;28(1):68. doi:10.1186/s12998-020-00356-z
78. Aboagye E, Karlsson ML, Hagberg J, Jensen I. Cost-effectiveness of early interventions for non-specific low back pain: a randomized controlled study investigating medical yoga, exercise therapy and self-care advice. J Rehabil Med. 2015;47(2):167–173. doi:10.2340/16501977-1910
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
